Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intranasal dexmedetomidine for cardiac function in sepsis
PACTR202511730546627Phase 4Not yet recruiting
- Sponsor
- Mostafa Ali
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in sepsis and septic shock (2 arms), sponsored by Mostafa Ali. Primary endpoint: Left ventricular ejection fraction. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on PACTR202511730546627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511730546627.